Antonios Ampatzoglou1, Charlotte L Williams1, Kiranjit K Atwal1, Catherine M Maidens1, Alastair B Ross2,3, Frank Thielecke3,4, Satya S Jonnalagadda5, Orla B Kennedy1, Parveen Yaqoob6. 1. Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK. 2. Department of Chemical and Biochemical Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden. 3. Nestlé Research Centre, Nestec Ltd, Vers-chez-les-Blanc, 1000, Lausanne 26, Switzerland. 4. Cereal Partners Worldwide, Ch du Viaduc 1, 1000, Lausanne, Switzerland. 5. General Mills Bell Institute of Health and Nutrition, 9000 Plymouth Ave N, Golden Valley, MN, 55427, USA. 6. Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK. p.yaqoob@reading.ac.uk.
Abstract
PURPOSE:Wholegrain (WG) consumption is associated with reduced risk of cardiovascular disease, but clinical data on inflammation and immune function is either conflicting or limited. The objective of this study was to assess the impact of increasing WG consumption to at least 80 g/day on markers of inflammation and glucose metabolism and on phenotypic and functional aspects of the immune system, in healthy, middle-aged adults with low habitual WG intake. METHODS: Subjects consumed a diet high in WG (>80 g/day) or low in WG (<16 g/day, refined grain diet) in a crossover study, with 6-week intervention periods, separated by a 4-week washout. Adherence to the dietary regimes was achieved by dietary advice and provision of a range of food products, with compliance verified by analysis of plasma alkylresorcinols (ARs). RESULTS: On the WG intervention, WG consumption reached 168 g/day (P < 0.001), accompanied by an increase in plasma ARs (P < 0.001) and fibre intake (P < 0.001), without affecting other aspects of dietary intake. On the WG arm, there were trends for lower ex vivo activation of CD4(+) T cells and circulating concentrations of IL-10, C-reactive protein, C-peptide, insulin and plasminogen activator inhibitor-1. The percentage of CD4(+) central memory T cells and circulating levels of adipsin tended to increase during the WG intervention. CONCLUSIONS: Despite the dramatic increase in WG consumption, there were no effects on phenotypic or functional immune parameters, markers of inflammation or metabolic markers.
RCT Entities:
PURPOSE: Wholegrain (WG) consumption is associated with reduced risk of cardiovascular disease, but clinical data on inflammation and immune function is either conflicting or limited. The objective of this study was to assess the impact of increasing WG consumption to at least 80 g/day on markers of inflammation and glucose metabolism and on phenotypic and functional aspects of the immune system, in healthy, middle-aged adults with low habitual WG intake. METHODS: Subjects consumed a diet high in WG (>80 g/day) or low in WG (<16 g/day, refined grain diet) in a crossover study, with 6-week intervention periods, separated by a 4-week washout. Adherence to the dietary regimes was achieved by dietary advice and provision of a range of food products, with compliance verified by analysis of plasma alkylresorcinols (ARs). RESULTS: On the WG intervention, WG consumption reached 168 g/day (P < 0.001), accompanied by an increase in plasma ARs (P < 0.001) and fibre intake (P < 0.001), without affecting other aspects of dietary intake. On the WG arm, there were trends for lower ex vivo activation of CD4(+) T cells and circulating concentrations of IL-10, C-reactive protein, C-peptide, insulin and plasminogen activator inhibitor-1. The percentage of CD4(+) central memory T cells and circulating levels of adipsin tended to increase during the WG intervention. CONCLUSIONS: Despite the dramatic increase in WG consumption, there were no effects on phenotypic or functional immune parameters, markers of inflammation or metabolic markers.
Authors: Brenda M Davy; Kevin P Davy; Richard C Ho; Stacy D Beske; Linda R Davrath; Christopher L Melby Journal: Am J Clin Nutr Date: 2002-08 Impact factor: 7.045
Authors: Philip C Calder; Namanjeet Ahluwalia; Fred Brouns; Timo Buetler; Karine Clement; Karen Cunningham; Katherine Esposito; Lena S Jönsson; Hubert Kolb; Mirian Lansink; Ascension Marcos; Andrew Margioris; Nathan Matusheski; Herve Nordmann; John O'Brien; Giuseppe Pugliese; Salwa Rizkalla; Casper Schalkwijk; Jaakko Tuomilehto; Julia Wärnberg; Bernhard Watzl; Brigitte M Winklhofer-Roob Journal: Br J Nutr Date: 2011-12 Impact factor: 3.718
Authors: Nuria Mateo Anson; Anna-Marja Aura; Emilia Selinheimo; Ismo Mattila; Kaisa Poutanen; Robin van den Berg; Robert Havenaar; Aalt Bast; Guido R M M Haenen Journal: J Nutr Date: 2010-11-24 Impact factor: 4.798
Authors: Majken K Jensen; Pauline Koh-Banerjee; Mary Franz; Laura Sampson; Morten Grønbaek; Eric B Rimm Journal: Am J Clin Nutr Date: 2006-02 Impact factor: 7.045
Authors: Denisa Margină; Anca Ungurianu; Carmen Purdel; George Mihai Nițulescu; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Tatyana I Burykina; Fotis Tekos; Aleksandra Buha; Dragana Nikitovic; Demetrios Kouretas; Aristidis Michael Tsatsakis Journal: Food Chem Toxicol Date: 2020-07-05 Impact factor: 6.023
Authors: Denisa Margină; Anca Ungurianu; Carmen Purdel; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Fotios Tekos; Robin Mesnage; Demetrios Kouretas; Aristidis Tsatsakis Journal: Int J Environ Res Public Health Date: 2020-06-10 Impact factor: 3.390